Literature DB >> 17078709

Azabicyclic amino acids by stereoselective dearomatizing cyclization of the enolates of N-nicotinoyl glycine derivatives.

Gareth Arnott1, Jonathan Clayden, Stuart D Hamilton.   

Abstract

[Structure: see text] On activation by pyridine N-acylation, enolates of N-nicotinoyl and N-isonicotinoyl glycine and alanine derivatives cyclize to yield 6,5-azabicyclic or 6,4-azaspirocyclic lactams. With an N-alpha-methyl-p-methoxybenzyl group the cyclization is diastereoselective; hydrogenation and deprotection yields azabicyclic amino acids in 94:6 er.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17078709     DOI: 10.1021/ol062126s

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

Review 1.  Cyclization-activated prodrugs.

Authors:  Paula Gomes; Nuno Vale; Rui Moreira
Journal:  Molecules       Date:  2007-11-12       Impact factor: 4.411

2.  Fused bicyclic piperidines and dihydropyridines by dearomatising cyclisation of the enolates of nicotinyl-substituted esters and ketones.

Authors:  Heloise Brice; Jonathan Clayden; Stuart D Hamilton
Journal:  Beilstein J Org Chem       Date:  2010-03-02       Impact factor: 2.883

3.  (3aS,7aS)-5-[(S)-3,3,3-Trifluoro-2-meth-oxy-2-phenyl-propano-yl]-2,3,4,5,6,7-hexa-hydro-1H-pyrrolo[3,4-c]pyridin-3(2H)-one monohydrate.

Authors:  Huichun Zhu; Michael B Plewe; Arnold L Rheingold; Curtis Moore; Alex Yanovsky
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-12-16

4.  Synthesis of some new mono- and bis-polycyclic aromatic spiro and bis-nonspiro-beta-lactams.

Authors:  Aliasghar Jarrahpour; Edris Ebrahimi
Journal:  Molecules       Date:  2010-01-22       Impact factor: 4.411

5.  Enantioselective one-carbon expansion of aromatic rings by simultaneous formation and chromoselective irradiation of a transient coloured enolate.

Authors:  Rakesh K Saunthwal; James Mortimer; Andrew J Orr-Ewing; Jonathan Clayden
Journal:  Chem Sci       Date:  2022-01-25       Impact factor: 9.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.